This page was printed from the Northern & Eastern Devon Formulary and Referral site at
Please ensure you are using the current version of this document
MHRA Drug safety Update July 2009: Abacavir-containing medicines should be used in line with current treatment guidelines and with caution in patients with high cardiovascular risk factors. Action should be taken to minimise all modifiable risk factors (e.g. smoking, high blood pressure, hyperlipidaemia, and diabetes).